In this study, 56 patients with MDRAB pneumonia admitted to our hospital from February 2019 to December 2021 were selected to explore the significance of polymyxin B-CSSS-tigecycline for the treatment of the disease on the levels of WBC count, serum CRP, and PCT, so as to provide clinical reference. Here, CRP is linked to pneumonia.